ATE483163T1 - Verfahren zur diagnose von tumoren durch messung des niveaus von apolipoprotein a-iv - Google Patents

Verfahren zur diagnose von tumoren durch messung des niveaus von apolipoprotein a-iv

Info

Publication number
ATE483163T1
ATE483163T1 AT06760823T AT06760823T ATE483163T1 AT E483163 T1 ATE483163 T1 AT E483163T1 AT 06760823 T AT06760823 T AT 06760823T AT 06760823 T AT06760823 T AT 06760823T AT E483163 T1 ATE483163 T1 AT E483163T1
Authority
AT
Austria
Prior art keywords
apolipoprotein
measuring
sample
apoa
tumors
Prior art date
Application number
AT06760823T
Other languages
English (en)
Inventor
Hans Dieplinger
Florian Kronenberg
Original Assignee
Vitateq Biotechnology Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vitateq Biotechnology Gmbh filed Critical Vitateq Biotechnology Gmbh
Application granted granted Critical
Publication of ATE483163T1 publication Critical patent/ATE483163T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57525—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the liver or pancreas
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57545—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the ovaries
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5755—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the uterine cervix, uterine corpus or endometrium
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT06760823T 2005-08-08 2006-08-08 Verfahren zur diagnose von tumoren durch messung des niveaus von apolipoprotein a-iv ATE483163T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0133305A AT502227B1 (de) 2005-08-08 2005-08-08 Verfahren zur diagnose von tumoren
PCT/AT2006/000336 WO2007016716A1 (en) 2005-08-08 2006-08-08 Method for diagnosing tumors by measuring the level of apolipoprotein a-iv

Publications (1)

Publication Number Publication Date
ATE483163T1 true ATE483163T1 (de) 2010-10-15

Family

ID=37238046

Family Applications (2)

Application Number Title Priority Date Filing Date
AT0133305A AT502227B1 (de) 2005-08-08 2005-08-08 Verfahren zur diagnose von tumoren
AT06760823T ATE483163T1 (de) 2005-08-08 2006-08-08 Verfahren zur diagnose von tumoren durch messung des niveaus von apolipoprotein a-iv

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT0133305A AT502227B1 (de) 2005-08-08 2005-08-08 Verfahren zur diagnose von tumoren

Country Status (8)

Country Link
US (1) US20100136583A1 (de)
EP (1) EP1913396B1 (de)
JP (1) JP2009505039A (de)
AT (2) AT502227B1 (de)
AU (1) AU2006279237A1 (de)
CA (1) CA2614474A1 (de)
DE (1) DE602006017228D1 (de)
WO (1) WO2007016716A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015069187A1 (en) 2013-11-05 2015-05-14 Agency For Science, Technology And Research Bladder Carcinoma Biomarkers
US11327078B2 (en) 2018-02-27 2022-05-10 Eisai R&D Management Co., Ltd. Monoclonal antibody against APOA4, immunological measurement method, and kit for measurement
CN120044256A (zh) * 2025-02-11 2025-05-27 中国人民解放军总医院第七医学中心 载脂蛋白apod缺失作为诊断宫颈癌分子标志物的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69625236T2 (de) * 1995-09-15 2003-08-21 Signet Laboratories, Inc. Verfahren zur reihenuntersuchung auf prostatakrebs durch messung des apolipoprotein-d-spiegels in körperflüssigkeiten
EP1218408A4 (de) * 1999-09-24 2003-02-26 Human Genome Sciences Inc 32 menschliche, sekretierte proteine
WO2003097879A2 (en) * 2002-05-22 2003-11-27 Fujisawa Pharmaceutical Co., Ltd. Method of identifying pancreatic ductal carcinoma-specific gene using pancreatic ductal cells, method of testing for pdc using said genes, and method of screening pharmaceutical candidate compounds for treating or preventing pdc
ES2217931B1 (es) * 2002-07-01 2006-02-16 Universidad De Barcelona Metodo de diagnostico de la evolucion de la masa intestinal absortiva en un individuo.
NZ562192A (en) * 2002-08-06 2009-07-31 Ciphergen Biosystems Inc Use of biomarkers for detecting ovarian cancer
DE10343815A1 (de) * 2003-09-22 2005-04-14 B.R.A.H.M.S Ag Verfahren zur Diagnose von Erkrankungen unter Bestimmung von Apolipoprotein C-I, und dessen Verwendung in der Therapie von Erkrankungen

Also Published As

Publication number Publication date
WO2007016716A1 (en) 2007-02-15
EP1913396B1 (de) 2010-09-29
AU2006279237A1 (en) 2007-02-15
AT502227B1 (de) 2007-08-15
AT502227A1 (de) 2007-02-15
US20100136583A1 (en) 2010-06-03
EP1913396A1 (de) 2008-04-23
DE602006017228D1 (de) 2010-11-11
JP2009505039A (ja) 2009-02-05
CA2614474A1 (en) 2007-02-15

Similar Documents

Publication Publication Date Title
ATE536553T1 (de) Verfahren zum nachweis grösserer ungünstiger kardiovaskulärer und zerebrovaskulärer ereignisse
NZ701807A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
HRP20130127T1 (hr) Prediktivni biomarkeri bubrežne sigurnosti i potpisi biomarkera za praä†enje funkcije bubrega
EP2319941A3 (de) Methode und vorrichtung zur korrelation von biomarker produktmengen mit krankheiten
NZ628843A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
NZ591437A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
JP2009501333A5 (de)
TW200641352A (en) Oxidizable species as an internal reference in control solutions for biosensors
EP3156925A3 (de) Copd-biomarkersignaturen
ATE425461T1 (de) Diagnose von hepatozellulärem karzinom
ATE548467T1 (de) Verfahren zur identifizierung von biomarkern mit eignung bei der diagnose biologischer zustände
ATE370414T1 (de) Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs
DE60315151D1 (de) Diagnostischer test zur bestimmung der konzentration einer transienten proteolytischen aktivität in zusammengesetzten biologischen medien
NZ606124A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
ATE503846T1 (de) Verfahren zur diagnose eines ovarialkarzinoms
ATE550668T1 (de) Verfahren zur identifizierung von patienten mit erhöhtem risiko für ein unerwünschtes herz- kreislauf-ereignis
RU2008103988A (ru) Способ диагностики рассеяного склероза
ATE483163T1 (de) Verfahren zur diagnose von tumoren durch messung des niveaus von apolipoprotein a-iv
ATE495267T1 (de) Diagnostisches verfahren zum nachweis von helicobacter pylori
DE602006015727D1 (de) Verfahren zur messung von plasmaspiegeln von pentraxin ptx3
ATE353544T1 (de) Verwendung des proteins masp als marker für kolorektale karzinome
ATE426168T1 (de) Verwendung von asc als marker fur kolorektalkarzinome
ATE557277T1 (de) Verfahren zur diagnose von endometriose mittels tfpi-2 protein
ATE466285T1 (de) Diagnose von leberzirrhose mittels eines für menschliches protoonkogenes protein spezifischen antikörpers
ATE455297T1 (de) Mikrosensor zur bestimmung von d-aminosäuren

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties